Bromhexine: Effect, Dosage & Notes
Bromhexine is a synthetic mucolytic agent derived from the alkaloid vasicine, which originates from the Adhatoda vasica plant. Since its introduction in the 1960s, bromhexine has become one of the most widely used expectorants worldwide. Its active metabolite ambroxol, which is also available as an independent drug, accounts for a significant portion of its therapeutic effect.
Bromhexine is used in conditions where excessive or viscous mucus impairs breathing and promotes the buildup of secretions in the airways. It helps make coughing more productive and supports the natural mucus clearance mechanisms of the respiratory tract. The drug is available in various formulations including tablets, syrups, and inhalation solutions.
Mechanism of Action
Bromhexine depolymerizes mucopolysaccharide fibers in the bronchial mucus, reducing its viscosity. Additionally, bromhexine stimulates the serous glandular cells of the bronchial mucosa to produce a thinner, more watery secretion. Through its active metabolite ambroxol, surfactant production in the type II pneumocytes is also stimulated, which additionally reduces the adhesion of mucus to bronchial walls. The combined mucolytic and secretomotor effect facilitates coughing up of secretions and improves mucociliary clearance.
Indications
Bromhexine is indicated for secretolytic therapy in acute and chronic bronchopulmonary diseases associated with disturbed mucus formation and transport. These include acute bronchitis, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, and bronchial asthma with mucus hypersecretion. Bromhexine is also used to facilitate expectoration in pneumonia and post-operative respiratory management. In Germany, bromhexine is also approved for use in children over 2 years of age in age-appropriate dosage forms.
Dosage and Administration
Standard adult dose is 8 to 16 mg three times daily. For children aged 6 to 12 years, 4 to 8 mg three times daily; for children aged 2 to 5 years, 4 mg two to three times daily. Bromhexine should be taken with plenty of fluids to support mucolytic efficacy. The duration of use in acute bronchitis is typically four to five days; in chronic conditions, use may extend over several weeks under medical supervision. Adequate hydration is a prerequisite for the drug to work effectively.
Side Effects
Bromhexine is generally well tolerated. The most common adverse effects are mild gastrointestinal complaints including nausea, vomiting, and diarrhea, which typically resolve with dose reduction or taking the drug with food. Allergic skin reactions such as urticaria and rash occur rarely. Severe hypersensitivity reactions including anaphylaxis have been reported in isolated cases and require immediate cessation of treatment. Headache and dizziness have been reported infrequently. Bromhexine does not cause relevant central nervous system side effects and is not sedating.
Interactions
When co-administered with antibiotics, bromhexine increases antibiotic concentration in bronchial secretions, which can be therapeutically advantageous in respiratory infections. This interaction has been documented for amoxicillin, erythromycin, cephalexin, and doxycycline. Bromhexine does not have clinically significant interactions with common cardiovascular drugs, antidiabetics, or anticoagulants. Combination with cough suppressants (antitussives) should be avoided because suppressing the cough reflex prevents expectoration of the loosened secretions.
Special Notes
Bromhexine is available without prescription in Germany in standard dosages. Patients with peptic ulcer disease should use bromhexine with caution due to its mild mucosal irritant properties. Use during the first trimester of pregnancy is not recommended; in the second and third trimesters, use should only be considered after careful risk-benefit assessment. During breastfeeding, use is not recommended because ambroxol (the active metabolite) passes into breast milk. Patients with rare hereditary disorders of galactose metabolism should not use lactose-containing formulations.
Related Topics
Frequently Asked Questions
What is the difference between bromhexine and ambroxol?
Ambroxol is the main active metabolite of bromhexine. Both have mucolytic properties, but ambroxol is more potent and has additional analgesic effects on the oral and pharyngeal mucosa. Many modern preparations use ambroxol directly rather than its prodrug bromhexine.
How quickly does bromhexine work?
The mucolytic effect begins within two to three hours of the first dose. Noticeable improvement in mucus clearance is typically observed after one to two days of regular use.
Why should bromhexine not be combined with cough suppressants?
Cough suppressants reduce or eliminate the cough reflex, which is necessary to expectorate the mucus that bromhexine has liquefied. Combining both would cause the loosened secretions to accumulate in the airways rather than being cleared.
Sources
- Fachinformation Bromhexin 8 mg, aktueller Stand
- EMA: Bromhexine hydrochloride: Core SmPC 2022
- Rubin BK: Mucolytics and secretolytics. Respir Care 2023